143 related articles for article (PubMed ID: 27247599)
1. Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder.
Baek JH; Kim HJ; Fava M; Mischoulon D; Papakostas GI; Nierenberg A; Heo JY; Jeon HJ
Psychiatry Investig; 2016 May; 13(3):321-6. PubMed ID: 27247599
[TBL] [Abstract][Full Text] [Related]
2. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
3. The Clinical Characteristics and Manifestation of Anxious Depression Among Patients With Major Depressive Disorders-Results From a Taiwan Multicenter Study.
Lin HL; Lee WY; Liu CH; Chiang WY; Hsu YT; Hsiao CF; Tsou HH; Liu CY
Psychiatry Investig; 2024 Jun; 21(6):561-572. PubMed ID: 38960433
[TBL] [Abstract][Full Text] [Related]
4. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D.
Fava M; Alpert JE; Carmin CN; Wisniewski SR; Trivedi MH; Biggs MM; Shores-Wilson K; Morgan D; Schwartz T; Balasubramani GK; Rush AJ
Psychol Med; 2004 Oct; 34(7):1299-308. PubMed ID: 15697056
[TBL] [Abstract][Full Text] [Related]
5. Does comorbid subthreshold anxiety predict treatment response in depression? Results from a naturalistic cohort study (the CRESCEND study).
Seo HJ; Song HR; Jeong S; Kim JB; Lee MS; Kim JM; Yim HW; Jun TY
J Affect Disord; 2014 Jan; 152-154():352-9. PubMed ID: 24144584
[TBL] [Abstract][Full Text] [Related]
6. Characterising anxiety in major depressive disorder and its use in predicting antidepressant treatment outcome: An iSPOT-D report.
Braund TA; Palmer DM; Williams LM; Harris AW
Aust N Z J Psychiatry; 2019 Aug; 53(8):782-793. PubMed ID: 30880405
[TBL] [Abstract][Full Text] [Related]
7. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension.
Fava M; Rush AJ; Alpert JE; Carmin CN; Balasubramani GK; Wisniewski SR; Trivedi MH; Biggs MM; Shores-Wilson K
Can J Psychiatry; 2006 Nov; 51(13):823-35. PubMed ID: 17195602
[TBL] [Abstract][Full Text] [Related]
8. Extended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depression.
Thase ME; Demyttenaere K; Earley WR; Gustafsson U; Udd M; Eriksson H
Depress Anxiety; 2012 Jul; 29(7):574-86. PubMed ID: 22753280
[TBL] [Abstract][Full Text] [Related]
9. Childhood trauma dependent anxious depression sensitizes HPA axis function.
Menke A; Lehrieder D; Fietz J; Leistner C; Wurst C; Stonawski S; Reitz J; Lechner K; Busch Y; Weber H; Deckert J; Domschke K
Psychoneuroendocrinology; 2018 Dec; 98():22-29. PubMed ID: 30086534
[TBL] [Abstract][Full Text] [Related]
10. Treating anxious depression using repetitive transcranial magnetic stimulation.
Diefenbach GJ; Bragdon L; Goethe JW
J Affect Disord; 2013 Oct; 151(1):365-8. PubMed ID: 23810361
[TBL] [Abstract][Full Text] [Related]
11. Extended release quetiapine fumarate as adjunct to antidepressant therapy in patients with major depressive disorder: pooled analyses of data in patients with anxious depression versus low levels of anxiety at baseline.
Bandelow B; Bauer M; Vieta E; El-Khalili N; Gustafsson U; Earley WR; Eriksson H
World J Biol Psychiatry; 2014 Feb; 15(2):155-66. PubMed ID: 24506289
[TBL] [Abstract][Full Text] [Related]
12. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
[TBL] [Abstract][Full Text] [Related]
13. The effect of desvenlafaxine 50 mg/day on a subpopulation of anxious/depressed patients: a pooled analysis of seven randomized, placebo-controlled studies.
Kornstein SG; Guico-Pabia CJ; Fayyad RS
Hum Psychopharmacol; 2014 Sep; 29(5):492-501. PubMed ID: 25196042
[TBL] [Abstract][Full Text] [Related]
14. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
Nelson JC
Depress Anxiety; 2010; 27(1):12-8. PubMed ID: 20013987
[TBL] [Abstract][Full Text] [Related]
15. Psychosocial factors associated with anxious depression.
Zhou E; Ma S; Kang L; Zhang N; Wang P; Wang W; Nie Z; Chen M; Xu J; Sun S; Yao L; Xiang D; Liu Z
J Affect Disord; 2023 Feb; 322():39-45. PubMed ID: 36375541
[TBL] [Abstract][Full Text] [Related]
16. Associations between immune activation and the current severity of the "with anxious distress" specifier in patients with depressive disorders.
Shim IH; Woo YS; Bahk WM
Gen Hosp Psychiatry; 2016; 42():27-31. PubMed ID: 27638968
[TBL] [Abstract][Full Text] [Related]
17. The role of anxious distress in immune dysregulation in patients with major depressive disorder.
Gaspersz R; Lamers F; Wittenberg G; Beekman ATF; van Hemert AM; Schoevers RA; Penninx BWJH
Transl Psychiatry; 2017 Dec; 7(12):1268. PubMed ID: 29217840
[TBL] [Abstract][Full Text] [Related]
18. A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.
Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Zarate CA
Bipolar Disord; 2015 Jun; 17(4):438-43. PubMed ID: 25400146
[TBL] [Abstract][Full Text] [Related]
19. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
Nelson JC; Delucchi K; Schneider LS
Int J Geriatr Psychiatry; 2009 May; 24(5):539-44. PubMed ID: 19334041
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of the effects of venlafaxine on anxiety associated with depression.
Rudolph RL; Entsuah R; Chitra R
J Clin Psychopharmacol; 1998 Apr; 18(2):136-44. PubMed ID: 9555599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
